Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers

COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA

NCT04732468 ·Status: TERMINATED ·Phase: PHASE1

Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

NCT04962308 ·Status: UNKNOWN ·Phase: PHASE4

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

NCT04516746 ·Status: COMPLETED ·Phase: PHASE3

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

NCT04636697 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

NCT04368988 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19

NCT04619628 ·Status: COMPLETED ·Phase: PHASE1

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)

NCT04961359 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine

NCT04953325 ·Status: COMPLETED ·Phase: PHASE4

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)

NCT04550351 ·Status: UNKNOWN ·Phase: PHASE1

Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19

NCT04922788 ·Status: COMPLETED ·Phase: PHASE3

COVID-19 VACCINE SAFETY AND EFFECTIVENESS

NCT05133609 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

NCT04686773 ·Status: COMPLETED ·Phase: PHASE2

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

NCT04894227 ·Status: COMPLETED ·Phase: PHASE4

Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)

NCT05633446 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults

NCT05559983 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19

NCT04844268 ·Status: UNKNOWN ·Phase: PHASE1

Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)

NCT05007951 ·Status: COMPLETED ·Phase: PHASE3

AZD1222 Vaccine for the Prevention of COVID-19

NCT04540393 ·Status: WITHDRAWN ·Phase: PHASE3

Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

NCT05599516 ·Status: UNKNOWN ·Phase: PHASE3

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

NCT05572879 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers

NCT04683484 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)

NCT04830800 ·Status: COMPLETED ·Phase: PHASE1

Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)

NCT04636333 ·Status: UNKNOWN ·Phase: PHASE1

Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults

NCT04783311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents

NCT04992208 ·Status: COMPLETED ·Phase: PHASE4